Antilymphocyte Globulin Versus OKT3 Induction Therapy in Cadaveric Kidney Transplantation: A Prospective Randomized Study
- 1 December 1992
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 20 (6) , 603-610
- https://doi.org/10.1016/s0272-6386(12)70227-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- ANTIBODIES AGAINST FUNCTIONAL LEUKOCYTE SURFACE MOLECULES IN POLYCLONAL ANTILYMPHOCYTE AND ANTITHYMOCYTE GLOBULINSTransplantation, 1991
- ANTILYMPHOBLAST GLOBULIN, CYCLOSPORINE, AND STEROIDS IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1990
- THE OKT3 IMMUNOSUPPRESSIVE EFFECTTransplantation, 1990
- Triple therapy immunosuppression in cadaveric renal transplantationTransplant International, 1990
- Muromonab CD3Drugs, 1989
- SEQUENTIAL ANTILYMPHOCTYE GLOBULIN/CYCLOSPORINE IMMUNOSUPPRESSION IN CADAVERIC RENAL TRANSPLANTATION. EFFECT OF DURATION OF ALG THERAPYTransplantation, 1989
- INDIVIDUALIZATION OF IMMEDIATE POSTTRANSPLANT IMMUNOSUPPRESSIONTransplantation, 1988
- OKT3 TREATMENT OF STEROID-RESISTANT RENAL ALLOGRAFT REJECTIONTransplantation, 1987
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complexCell, 1982